Boston Scientific Raises Outlook on Continued Cardiovascular Growth

Boston Scientific BSX 3.95%increase; green up pointing triangle recorded higher third-quarter sales and raised its full-year earnings guidance on the back of continued growth in its cardiovascular segment.

The medical device company logged net income of $755 million, or 51 cents a share, up from $469 million, or 32 cents a share the year prior.